Innovator IBD ETF Leaders ETF (LDRS) Research
This investment vehicle endeavors to mirror the performance of the IBD® ETF Leaders Index, before any deductions for fees or operational expenses. Typically, it dedicates at least 80% of its total assets, which may incorporate leveraged borrowings, to the specific exchange-traded investment companies that form the index. The portfolio generally maintains holdings in all the index's constituent securities, proportionate to their respective weightings within the index. The benchmark itself is a proprietary, rules-based index conceived and established by Investor's Business Daily®, designed with the ambition of potentially outperforming the broader equity and fixed income sectors. It operates as a non-diversified fund.
Market snapshot
- Symbol
- LDRS
- Price
- $28.27
- Day change
- -0.53%
- Market cap
- $8.2M
- 52-week range
- 24.03-29.77
- Sector
- Financial Services
- Industry
- Asset Management
Peer companies
- ETRACS Alerian Midstream Energy High Dividend Index ETN (AMND)
- AVDR US LargeCap ESG ETF (AVDG)
- Morgan Creek-Exos Active SPAC Arbitrage ETF (CSH)
- Euclid Capital Growth ETF (EUCG)
- ProShares Managed Futures Strategy ETF (FUT)
- Defiance Nasdaq Junior Biotechnology ETF (IBBJ)
- Invesco Russell 1000 Low Volatility Factor ETF (OVOL)
- Invesco Dynamic Retail ETF (PMR)
Open Innovator IBD ETF Leaders ETF (LDRS) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.